Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by Alex1726on Apr 10, 2023 12:29pm
195 Views
Post# 35386857

Almost half a year

Almost half a year Without any financial information. Can you name one , just one company that has not released his financial results for 2022. I expect the resutls to be bad and very little will have been done regarding the PGX scale up , we will probably hear something like : we received submission from few engineering firms and a decision will be made in the coming weeks. And what about the AV PILL clinical trial , i am pretty sure they still have not finished to recruit the 94 patients. So disappointing 
financials results and no advancement for the new projects.

Not long agao Gagnon was talking about a nasdaq listing , it should be enough to let you know that he does not really knows where is going.
<< Previous
Bullboard Posts
Next >>